Serial #97006165
DEAD

Serial Number

97006165

Owner

NIPPON DENKI KABUSHIKI KAISHA

Attorney

LEIGH ANN LINDQUIST

Filing Date

Sep 1, 2021

Add to watchlist:

No watchlists yet
View on USPTO

Serial #97006165 Trademark

Serial Number: 97006165

Serial #97006165 is a trademark filed by NIPPON DENKI KABUSHIKI KAISHA on September 1, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

NIPPON DENKI KABUSHIKI KAISHA (602 trademarks)

7-1, SHIBA 5 CHOME
TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

September 1, 2021

Registration Date

Not Registered

Published for Opposition

December 13, 2022

Goods & Services

Downloadable and recorded computer software for data analysis; downloadable computer software for use in making prediction from data analysis; downloadable computer software for use in predicting data; downloadable computer software for use in predicting data in the field of artificial intelligence; downloadable computer software using artificial intelligence for use in software development; computer hardware, downloadable computer programs and downloadable computer software for image processing; computer hardware and downloadable computer software for image analysis; computer display screens; computer display monitors; monitors for computers; computer hardware and downloadable computer software for operating medical imaging apparatus; electronic sensors; infrared sensors; motion sensors; alarm sensors; downloadable computer software for providing health, wellness, healthcare, and medical information; downloadable computer software for retrieving, analyzing, and generating reports on a user's health and wellness from data generated by wearable digital electronic devices; downloadable computer software for measuring biometric data; scientific apparatus and instruments for measuring protein

Diagnostic reagents for medical purposes; diagnostic reagents for medical use, namely, aptamers; medical diagnostic assays for testing of body fluids; medical diagnostic assays for analysis of biological samples in the nature of bodily fluids

Market analysis and research services; Assistance, advisory services and consultancy with regard to business planning, business analysis, business management, and business organization; Business assistance, advisory and consulting services in the field of healthcare; business development services; business management, consultation and planning; business research; business data analysis

Medical analysis for the diagnosis and treatment of persons; medical, medicinal and pharmaceutical consultancy; providing information relating to medical services; massages; health care consultancy; providing health care information; providing health data analysis, namely, medical analysis services for diagnostic purposes; health assessment services; providing health information; analysis of proteins in biological samples for medical diagnostic purposes; providing health data analysis services in the nature of medical analysis services for diagnostic purposes and delivery of health information related thereto for treatment, diagnostic and providing personal health information purposes; providing health improvement advice, namely, health assessment services

Medical imaging apparatus for use in diagnosing medical conditions and medical analysis; electronic apparatus, namely, stand alone displays for medical images; medical imaging apparatus, namely, apparatus for displaying medical images; general wellness instruments and apparatus, namely, health monitoring devices for storing, relaying, tracking, measuring and displaying biometric data, body movement, and heart rate

Providing temporary use of on-line non-downloadable computer software for data analysis; Design and development of computer hardware and computer software; design and development of computer systems; consultancy services relating to the design, development and use of computer hardware and software; computer programming; installation, maintenance and repair of computer software; technological research in the field of healthcare and biotechnology; cloud computing; software as a service (SaaS) services featuring software for use in data analysis and data prediction; providing on-line non-downloadable software for data analysis; providing on-line non-downloadable software for use in predicting data; providing on-line non-downloadable software for image processing; providing on-line non-downloadable software for image analysis; technical support services, namely, troubleshooting of computer software problems; providing information about the design and development of computer software, systems and networks; technology consultation services in the fields of information and communications technology; technical advisory services relating to computer programs; pharmaceutical drug development services; pharmaceutical research and development; development of pharmaceutical preparations and medicines; Technical data analysis, namely, analysis of biometric data; health data analysis, namely, medical analysis services for research purposes; analysis of proteins in biological samples for medical research purposes; providing health data analysis services in the nature of medical analysis services for research purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 8, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 8, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 4, 2025 EXRA
SOU EXTENSION 4 GRANTED
Feb 4, 2025 EX4G
SOU EXTENSION 4 FILED
Feb 3, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 3, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 24, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jul 23, 2024 EX3G
SOU EXTENSION 3 FILED
Jul 23, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 23, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 1, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jan 30, 2024 EX2G
SOU EXTENSION 2 FILED
Jan 30, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 30, 2024 EEXT
ASSIGNED TO EXAMINER
Oct 26, 2023 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 28, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jul 26, 2023 EX1G
SOU EXTENSION 1 FILED
Jul 26, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 26, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 7, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 13, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 13, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 23, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 7, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 31, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 31, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 31, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 31, 2022 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 6, 2022 GNRN
NON-FINAL ACTION E-MAILED
May 6, 2022 GNRT
NON-FINAL ACTION WRITTEN
May 6, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 26, 2022 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Oct 19, 2021 AMPX
ASSIGNED TO LIE
Oct 19, 2021 ALIE
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 15, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 14, 2021 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Sep 7, 2021 PARI
NEW APPLICATION ENTERED
Sep 4, 2021 NWAP